Immunohistochemical biomarkers are prognostic relevant in addition to the ESMO-ESGO-ESTRO risk classification in endometrial cancer
- Resource Type
- Article
- Authors
- Vrede, S.W.; van Weelden, W.J.; Visser, N.C.M.; Bulten, J.; van der Putten, L.J.M.; van de Vijver, K.; Santacana, M.; Colas, E.; Gil-Moreno, A.; Moiola, C.P.; Mancebo, G.; Krakstad, C.; Trovik, J.; Haldorsen, I.S.; Huvila, J.; Koskas, M.; Weinberger, V.; Bednarikova, M.; Hausnerova, J.; van der Wurff, A.A.; Matias-Guiu, X.; Amant, F.; Snijders, M.P.L.M.; Küsters-Vandevelde, H.V.N.; Reijnen, C.; Pijnenborg, J.M.A.
- Source
- In Gynecologic Oncology June 2021 161(3):787-794
- Subject
- Language
- ISSN
- 0090-8258